Impact of atrioventricular node ablation and pacing therapy on clinical course in patients with permanent atrial fibrillation and unstable ventricular tachycardia induced by rapid ventricular response: Follow-up study

Croatian Medical Journal

Volumn 46, Issue 6, 2005, Pages 929-935

  Petrač, Dubravko ^a   Radič, Berislav ^a   Radeljič, Vjekoslav ^a   Hamel, Duško ^a   Filipović, Jakša ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CATHETER ABLATION; CAUSE OF DEATH; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; MORTALITY; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SUDDEN DEATH;

ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; TIME FACTORS;

EID: 31844455320     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol. 1995;26:555-73.
2. Scheinman M. NASPE survey on catheter ablation. Pacing Clin Electrophysiol. 1995;18:1474-8.
3. Fitzpatrick AP, Kourouyan HD, Siu A, Lee RJ, Lesh MD, Epstein LM, et al. Quality of live and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J. 1996;131:499-507.
4. Geelen P, Goethals M, de Bruyne B, Brugada P. A prospective hemodynamic evaluation of patients with chronic atrial fibrillation undergoing radiofrequency catheter ablation of the atrioventricular junction. Amer J Cardiol. 1997;80:1606-9.
5. Petrač D, Radić B, Holjevac I, Hamel D. Influence of AV junction radiofrequency catheter ablation on the clinical outcome in patients with atrial fibrillation. In: Vardas PE, editor. Europace '97. Bologna: Monduzzi Editore; 1997. p. 1003-7.
6. Schumacher B, Lüderitz B. Rate issue in atrial fibrillation: consequences of tachycardia and therapy for rate control. Am J Cardiol. 1998;82(8A):29N-36N.
7. Twidale N, McDonald T, Nave K, Seal A. Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. Pacing Clin Electrophysiol. 1998;21(2 Pt 1):641-51.
8. Lee SH, Chen SA, Tai CT, Chiang CE, Wen ZC, Cheng JJ, et al. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol. 1998;31:637-44.
9. Gallagher MM, Camm JJ. Classification of atrial fibrillation. Pacing Clin Electrophysiol. 1997;20:1603-5.
10. Petrač D, Radić B, Hamel D, Vukosavić cross D sign, Nikolić V. The clinical outcome of patients with atrial fibrillation after radiofrequency ablation of the atrioventricular junction. G Ital Cardiol 1998;28 Suppl 1:329-33.
11. Savelieva I, Camm AJ. Atrial fibrillation and heart failure: natural history and pharmacological treatment. Europace 2004;5 Suppl 1:5-19.
12. Völler H. In defense of current treatment options: where are we now? Eur Heart J Suppl. 2005;7 Suppl E:4-9.
13. Wilber DJ, Olshansky B, Moran JF, Scanlon PJ. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation. 1990;82:350-8.
14. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet. 1997;349:667-74.
15. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML; MADIT-II Investigators. Analysis of mortality in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol. 2004;43:1459-65.
16. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J. 2001;22:1374-450.
17. Wood MA, Brown-Mahoney C, Kay GN, Ellenbogen KA. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation. 2000;101:1138-44.
18. Jensen SM, Bergfeldt L, Rosenqvist M. Long-term follow-up of patients treated by radiofrequency ablation of the atrioventricular junction. Pacing Clin Electrophysiol. 1995;18(9 Pt 1):1609-14.
19. Darpö B, Walfridsson H, Aunes M, Bergfeldt L, Edvardsson N, Linde C, et al. Incidence of sudden death after radiofrequency ablation of the atrioventricular junction for atrial fibrillation. Am J Cardiol. 1997;80:1174-7.
20. Twidale N, McDonald T, Nave K, Seal A. Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. Pacing Clin Electrophysiol. 1998;21(4 Pt 1):641-51.
21. Stein KM, Euler DE, Mehra R, Seidl K, Slotwiner DJ, Mittal S, et al. Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients? J Am Coll Cardiol. 2002;40:335-40.
22. Timmermans C, Smeets JL, Rodriguez LM, Vrouchos G, Van den Dool A, Wellens HJ. Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1995;76:492-4.
23. Stein KM, Karagounis LA, Markowitz SM, Anderson JL, Lerman BB. Heart rate changes preceding ventricular ectopy in patients with ventricular tachycardia caused by reentry, triggered activity, and automaticity. Am Heart J. 1998;136:425-34.
24. Lerman BB. Mechanoelectrical feedback: maturation of a concept. J Cardiovasc Electrophysiol. 1996;7:17-9.
25. Garcia-Alberola A, Yli-Mäyry W, Block M, Haverkamp W, Martinez-Rubio A, Kottkamp H, et al. RR interval variability in irregular monomorphic ventricular tachycardia and atrial fibrillation. Circulation. 1996;93:295-300.
26. Cranefield PF, Aronson RS. Torsades de pointes and other pause-induced ventricular tachycardias: the short-long-short sequence and early afterdepolarizations. Pacing Clin Electrophysiol. 1988;11(6 Pt 1):670-8.
27. Grönefeld GC, Mauss O, Li YG, Klingenheben T, Hohnloser SH. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study. J Cardiovasc Electrophysiol. 2000;11:1208-14.
28. Olgin JE, Scheinman MM. Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction. J Am Coll Cardiol. 1993;21:557-64.
29. Petraeč D, Radić B, Vukosavić cross D sign, Birtić K. Late clinical outcome after radiofrequency catheter ablation of idiopathic ventricular tachycardia: follow-up study. Croat Med J. 2002;43:20-4.